Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on NATIXIS. We currently have 6 research reports from 1 professional analysts.
|09Dec16 01:44||GNW||NATIXIS :Number of shares and voting rights at 30 November 2016|
|09Nov16 02:47||GNW||NATIXIS :Number of shares and voting rights at October 31, 2016|
|08Nov16 04:35||GNW||NATIXIS :THIRD-QUARTER 2016 AND NINE-MONTH 2016 RESULTS|
|12Oct16 04:37||GNW||NATIXIS :Preparation of the Q3-2016 financial disclosures: CIB restated quarterly series|
Frequency of research reports
Research reports on
CIB again and again...
09 Nov 16
Natixis has just released its Q3 16 results. Total income is roughly in line with expectations at €1.92bn but 2.6% higher versus our own expectations (once adjusted for corporate centre revenues). Total expenses are, however, 2.1% above consensus expectations and 2% above our expectations. Loan losses at €69m are below consensus expectations (at €81m) and above our €58m forecasts. All in all, operating revenues at €408m are 2.5% short of expectations but 4% higher than our numbers. The CET1 ratio at 11.2% is 20bp higher qoq and 60bp higher versus Q4 15.
Mixed P&L results, capital generation going on
29 Jul 16
Natixis released its Q2 16 earnings. Total revenues are 4% higher than expectations. With costs 4% higher than consensus forecasts and total loan losses in line with expectations, the operating profit is 4% higher than expectations. CET1 ratio at 11% (after accrual dividend) is 20bp higher than Q1 16 and 225bp above the ratio required by regulators.
Earnings miss expectations on the back of higher expenses...
10 May 16
Natixis released its Q1 16 earnings this morning. Total revenues at €2.08bn are 0.5% short of expectations. Expenses were 2% higher than forecasts due to a higher contribution to the Single resolution fund and expenses in the CIB. Cost of risk at €88m, although higher than the Q1 15 number of €78m, is in line with expectations. Reported profit before tax at €407m (of which -€13m non-operating items) is therefore 8% lower than forecasts. The fully-loaded CET1 ratio (after payment of the dividend – a 50% pay-out ratio) is 20bp higher than in the last quarter at 9.9%.
Strong set of results
11 Feb 16
Natixis' Q4 15 earnings release: Strong results versus expectations as revenues are higher than expectations and the cost of risk much better than expected, profit before tax is 20% ahead of consensus. Natixis has just still proven its ability to create value for shareholders as the CET1 ratio is at 12.2% (phased-in and before dividends). The payout ratio is 50% and a €0.10ps dividend has been announced.
Capital back in shareholders' hands...
05 Nov 15
Natixis' Q3 earnings release was quite strong. Total revenues were a bit lower than expected (at €1,956m), 2% short of expectations. Total expenses were roughly in line with expectations and cost of risk a bit lower than expected. PBT is therefore roughly in line with expectations. CET1 ratio is 20bp higher than Q2 15 (11.2% vs 11%).
Good revenue growth...
31 Jul 15
Total revenues (excluding exceptional items) were slightly higher than company-compiled consensus (€2,175m vs €2,128m). Expenses were in line with consensus and so was the cost of risk. Gross operating income after tax was therefore 9% higher than consensus. The good news also being that growth was not made exclusively at the cost of the balance sheet as RWA recorded a 1% drop ytd (at constant exchange rates).
Making Mobiles Better
17 Jan 17
Mobile phones are increasingly the key connection for the modern world. This means that the performance of mobile phones, and their networks, is going to become more critical for all the apps and businesses that rely on them. New technologies such as VR, AR, and AV will need better, more reliable connections to really move into the mainstream. In this thematic piece we attempt to identify some of the most important issues facing mobile phone networks and their users, and start to identify solutions and enablers that will solve these problems and create value by doing so.
The Monthly January 2017
09 Jan 17
Despite all the hullaballoo of the Brexit vote and the subsequent election of Donald Trump as the next US President, the UK stock market prospered last year, especially in the latter few months of 2016. The combination of a depreciating currency – making $ earnings more valuable in relative terms - and the Trump emphasis on infrastructure expenditure drove the stock market higher
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
N+1 Singer - Best Ideas 2017 - Top picks
04 Jan 17
Today we publish our Best Ideas for 2017 - 12 stocks that we believe have excellent prospects in the current year together with a detailed discussion of what we see as the key sector and market themes for 2017. Our top picks are Cineworld, Elementis, Herald Investment Trust, Hill & Smith, IQE, MySale, Redde, ReNeuron, RhythmOne, SDL, Servelec and Severfield.
N+1 Singer - Morning Song 16-01-2017
16 Jan 17
As the birthplace of Stephenson, Armstrong and Swan, the North East of England has a proud history of industrial and technological innovation. Despite local economic challenges, the region’s industrial heritage lives on through continuing success in high end engineering and technology. The recent takeovers of private equity backed SMD (subsea robotics) and Nomad Digital (wi-fi on the railways) are testament to this. The North East has also emerged as a leader in genetics and genomics with an enviable life sciences and healthcare infrastructure. Against this backdrop, we expect the region to continue to throw up attractive IPO candidates to build on the six new listings in the past three years. We expect 2017 to be far kinder to the existing portfolio of North East plcs than 2016 (a year to forget) with recent management changes one important theme for the new year. Our top picks are Hargreaves Services, Quantum Pharma and Zytronic (all N+1 Singer Corporate clients) and we are Buyers of Northgate and Grainger.
N+1 Singer - Morning Song 19-01-2017
19 Jan 17
Actual Experience (ACT LN) 2017 – a milestone year for revenue | Bagir Group (BAGR LN) Independent NED appointment to strengthen Board composition | Bioquell (BQE LN) Reassuring pre-close statement | Carador Income Fund (CIFU LN) Q4 dividend increased to 2.75c, 0.5c higher than forecast | FreeAgent (FREE LN) Contract with Royal Bank of Scotland | Halfords Group (HFD LN) Excellent Q3 update, special divi and confidence in FX mitigations | N Brown Group (BWNG LN) Robust peak trading with reversal of drag from older titles | NCC Group (NCC LN) Interims confirm underlying business sound | St Ives (SIV LN) Downgrade | Summit Therapeutics (SUMM LN) Dr David Roblin appointed Chief Operating Officer and R&D President | Wilmington Group (WIL LN) Acquisition – Further scaling of Healthcare